David J. Maron MD, FACC, FAHAC.F. Rehnborg Professor of Medicine; Chief, Stanford Prevention Research Center; Director, Preventive Cardiology, Stanford University School of Medicine, Stanford, California
Dr. Maron is the C.F. Rehnborg Professor of Medicine at Stanford University School of Medicine where he serves as Chief of the Stanford Prevention Research Center and Director of Preventive Cardiology.
Dr. Maron is a cardiologist who has conducted clinical trials of secondary prevention of coronary artery disease. He was a member of the team that designed the COURAGE trial, which examined the impact of adding PCI to guideline-directed medical therapy in patients with stable coronary disease. He was co-chair and principal investigator of the ISCHEMIA trial, an NIH-funded study that tested the benefits of cardiac catheterization and revascularization added to guideline-directed medical therapy in 5,000 patients with stable coronary artery disease and at least moderate ischemia.
DisclosuresDr. Maron has no relevant disclosures.
Recent Contributions to PracticeUpdate:
- CT or Invasive Coronary Angiography in Stable Chest Pain
- ISCHEMIA Trial Outcomes Based on CAD and Ischemia Severity
- Cardiac Mortality in Patients Randomised to Elective Coronary Revascularisation Plus Medical Therapy or Medical Therapy Alone
- Survival After PCI or CABG in Diabetics With Multivessel Coronary Disease